The artificial pancreas can provide value to the health system.
How are pharma, clinical, and startup execs addressing some of the biggest challenges facing their businesses today?
MM&M honors 40 upstarts and veteran innovation gurus.
This program is designed to enable entrepreneurs and biopharma marketers to engage in an intelligent way to explore beyond-the-pill partnerships.
The first days at SXSW Health went deep on entrepreneurship and the marketing thereof.
A bout with Lyme disease led Yee to found a company that helps patients measure and track their breathing patterns.
Drugmakers have flirted with these pilots or partnerships, but few have fully embraced partnerships with digital health startups.
Rep. Price to answer questions at confirmation hearing; 22 drugmakers invest in fighting disease in poor countries; FDA approves generic of Jazz's Xyrem
The Roche veteran says that people who work in digital health need to touch others in a meaningful way.
A 2005 study estimated that 3.6 million people do not receive nonemergency medical care because they don't have access to transportation.
Pure Communications CEO Andrea Johnston will lead the combined agency.
The partnership is aimed at helping later-stage health startups grow their businesses with marketing and brand strategy advice.
Sproutel CEO Aaron Horowitz talks about how Jerry the Bear came to life and why endocrinologists are stocking the bear in their offices.
The new company, iBeat, plans to market a wearable device that can detect the symptoms of cardiac arrest and heart attacks.
It's a common refrain in healthcare and among patients, providers, and payers: Despite massive investment, no one has figured out how to change human behavior.
The Siri for Seniors took the top prize at the second MM&M Shark Tank for its annual healthcare conference.
The FTC asks for more info about Pfizer-Allergan deal; the FDA loosens guidelines for abortion-inducing drug; startup to deliver Truvada through an app
The newly launched tools aim to reduce the time and costs of marketing new drugs by "debugging" the lab environment.
The digital health sector brought in an estimated $6 billion in funding in 2015.
The drugmaker led a Series C fundraising round totaling $175 million. The funding will be used to accelerate clinical trials.
"Me-too" drugs may help lower costs; start-ups send doctors to your home; the FDA is likely to appeal the Amarin ruling
The health insurer will offer Fit4D's diabetes coaching program to its members after testing the program during a pilot last year.